FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/01/2024
Voltar para busca
Dado oficial do USPTO
BLUE EARTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BLUE EARTH
ST13
US500000079334964Classe
1, 5, 42, 44
Pedido
79334964
Registro
7159550
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
07/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
02/12/2021
Data de registro
12/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/09/2023
Última transação
12/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
ENGEL, MICHAEL
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Blue Earth Diagnostics Limited
Representantes
Molly Hunsinger Ladas & Parry LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers for laboratory or research use; alpha- and beta-emitting radionuclides for use in radionuclide therapy; radioactive elements for scientific purposes; synthetic amino acids for use in PET imaging and radionuclide therapy; reagents for use in PET imaging and radionuclide therapy; non-medical diagnostic scanning agents for in-vivo use; non-medical chemicals for use in molecular imaging
Classe 5
PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; diagnostic and therapeutic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in molecular imaging for medical use; pharmaceutical preparationsradiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; radiopharmaceuticals used in the field of nuclear medicineintended for medical imaging and therapy
Classe 42
Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in relation to disease diagnosis and treatment; scientific and medical research in relation to molecular imaging; development of molecular imaging products; development of non-medical molecular imaging services; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services
Classe 44
Medical services; Positron Emission Tomography (PET) medical imaging services; radionuclide therapy services; medical imaging services; medical services in the diagnosis and treatment of conditions in the body; providing medical consultancy in relation to the aforesaid services; development of medical molecular imaging services
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/12/2023
FIMP
FINAL DISPOSITION PROCESSED
14/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/08/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
29/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
30/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/05/2023
PUBO
PUBLISHED FOR OPPOSITION
30/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/04/2023
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
14/02/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
08/01/2023
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/12/2022
RFNT
REFUSAL PROCESSED BY IB
27/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/11/2022
RFRR
REFUSAL PROCESSED BY MPU
07/11/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
25/09/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/09/2022
CNRT
NON-FINAL ACTION WRITTEN
13/09/2022
DOCK
ASSIGNED TO EXAMINER
13/09/2022
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/06/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
29/05/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/04/2022
MAFR
APPLICATION FILING RECEIPT MAILED
22/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/03/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
16/03/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BLUE EARTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.